-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
January 01, 2001 - Drug therapy appears to
have little effect on total mortality after 5 to 7 years of
treatment in lower-risk … after 5 to 10 years of
treatment; the incremental benefit from beginning
therapy earlier is, therefore … elderly, and younger people with mul-
tiple risk factors or with diabetes. … American Diabetes Association. … American Diabetes Association: clinical
practice recommendations 1999.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
April 09, 2001 - Drug therapy appears to have little effect on total mortality after 5 to 7 years of treatment in lower-risk … after 5 to 10 years of treatment; the incremental benefit from beginning therapy earlier is, therefore … elderly, and younger people with multiple risk factors or with diabetes. … American Diabetes Association. … American Diabetes Association: clinical practice recommendations 1999.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obstructive-sleep-apnea-in-adults-screening
November 15, 2022 - . 4 Mandibular advancement devices (MADs) are an alternative therapy to positive airway pressure for … 16 Surgical interventions for OSA are available, but they generally are not considered first-line treatments … or discomfort. 15 , 16 In general, the adverse events related to positive airway pressure and MAD therapy … The focus of this recommendation is first-line therapies for OSA. … Surgical therapies are typically reserved for patients who do not respond to first-line therapies or
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/latent-tuberculosis-infection-adults
November 22, 2022 - 25 Some evidence from observational studies has explored the association between poorly controlled diabetes … However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes … TB exposure, HIV infection, risk factors increasing risk of progression to active disease (such as diabetes … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/VwvmgA5bLZZJhK6YSqRonU
November 01, 2022 - • Treatment with continuous positive airway pressure or mandibular advancement devices can improve … apnea-hypopnea index, Epworth Sleepiness Scale score, and blood pressure) in populations referred for
treatment … outcomes associated with untreated OSA include cardiovascular disease and cerebrovascular
events, type 2 diabetes
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/n6zHNuxCoZRTdKJ_m2JFtU
July 07, 2009 - Additional risk factors include:
• Smoking, alcohol use, exposure to ultraviolet light, diabetes, corticosteroids … There is evidence that early treatment of refractive error, cataracts, and age-related macular degeneration
-
www.uspreventiveservicestaskforce.org/uspstf/announcements/appointment-four-new-us-preventive-services-task-force-members
February 08, 2016 - is a family physician and obstetrician/gynecologist with expertise in the prevention, diagnosis, and treatment … Mangione is an internal medicine physician with expertise in diabetes, health disparities, aging, and
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/asymptomatic-carotid-artery-stenosis-screening
August 04, 2020 - carotid artery stenosis, including older age, male sex, hypertension, smoking, hypercholesterolemia, diabetes … Treatment
There are both medical and surgical options available for the treatment of carotid artery … disease and often includes statins, antiplatelet medications, management of hypertension and diabetes … compared with best medical therapy alone were mixed. … conducted during the 1990s. 8 Many study participants had hypertension, coronary artery disease, or diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening-september-2016
September 06, 2016 - Some evidence from observational studies has explored the association between poorly controlled diabetes … However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes … It does not recommend systematic testing for LTBI among persons who have diabetes, engage in harmful … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/pancreatic-cancer-screening-1996
January 01, 1996 - gastrointestinal bleeding, which may be life-threatening. 37 Additional randomized controlled trials of adjuvant therapy … New modalities being explored include immunotherapy 41 and hormonal therapy. 42
Return to Table … Surgical treatment of ductal pancreatic carcinoma. … Surgical treatment of pancreatic cancer. The United States experience. … New-onset diabetes mellitus as a harbinger of pancreatic carcinoma.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZU6FKBKNpGWxTQxp3oTe7J
March 28, 2017 - because of family
history or presence of conditions associated with celiac disease,
such as type 1 diabetes … Although
there continues to be research on pharmacological treatments for
celiac disease,46-49 such treatments … are considered an adjunct to a
gluten-free diet, which remains the mainstay of therapy. … Villous atrophy and negative celiac serology:
a diagnostic and therapeutic dilemma. … controlled study to evaluate
treatment of asymptomatic coeliac disease in type 1
diabetes.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/cardiovascular-disease-risk-screening-with-electrocardiography
June 12, 2018 - each included study, 1 investigator extracted pertinent information about the populations, tests or treatments … benefits and harms of preventive medications to reduce cardiovascular risk (ie, aspirin and lipid-lowering therapy … Those with positive findings were referred to cardiologists, and all subsequent investigations and treatments … therapy at baseline. … , and blood pressure–lowering therapy.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/k_QR3hvh2jVSPPLu6Q6m6r
November 13, 2022 - Statin therapy was not significantly associated with increased diabetes risk overall (RR,
1.04 [95% CI … Pravastatin
and the development of diabetes mellitus: evidence
for a protective treatment effect in the … Statin therapy: diabetes mellitus risk
and cardiovascular benefit in primary prevention. … Cardiovascular benefits and diabetes risks
of statin therapy in primary prevention: an analysis
from … Risk of
incident diabetes with intensive-dose compared
with moderate-dose statin therapy:
a meta-analysis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cBv4SGePTvo7Er2HGFtbsN
October 01, 2012 - reduce the risk for CHD events versus not screening, the effect of
identifying high-risk persons on treatment … The net benefit of the use of aspirin and
the intensity of lipid-lowering therapy depends on a per-
son … abnormality (as a result of
a true- or false-positive result) can lead to invasive confir-
matory testing and treatments … should
also evaluate harms associated with screening as well as
those related to additional testing and therapies … adds to traditional risk assessment with Framingham
risk factors, because this could lead to change in treatments
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/e9f8a_uGMXxSbBUxpRPkrc
June 18, 2024 - Two trials
of interpersonal therapy with limited counseling to change diet
and physical activity found … Since the prior review for the USPSTF, several new pharmaco-
therapy agents have been approved for use … Diabetes Care. 2014;37(2):317-324.
doi:10.2337/dc13-1571
42. … Diabetes Care. 2013;36(7):1891-1897.
doi:10.2337/dc12-1708
72. … Family-based obesity treatment, then
and now: twenty-five years of pediatric obesity
treatment.
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/obstructive-sleep-apnea-in-adults-screening
November 15, 2022 - . 4 Mandibular advancement devices (MADs) are an alternative therapy to positive airway pressure for … 16 Surgical interventions for OSA are available, but they generally are not considered first-line treatments … or discomfort. 15 , 16 In general, the adverse events related to positive airway pressure and MAD therapy … The focus of this recommendation is first-line therapies for OSA. … Surgical therapies are typically reserved for patients who do not respond to first-line therapies or
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/lipid-disorders-in-children-screening
July 18, 2023 - without an inherited component from single-nucleotide variants with smaller additive effects. 2-4
Therapies … For KQ4, RCTs of treatments for dyslipidemia including drugs, behavioral counseling, and supplements … Twenty-two fair- to good-quality trials (n = 2257) examined the effectiveness of various lipid-lowering treatments … of secondary comorbid conditions (eg, diabetes, hypothyroidism) and identification and treatment of … Statin use and the risk of type 2 diabetes mellitus in children and adolescents.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2021-uspstf-annual-report-to-congress.pdf
January 01, 2021 - • Assess the effects of lifestyle interventions and medical treatments for screen-detected
prediabetes … highest prevalence of diabetes … • Assess the effects of lifestyle interventions and medical
treatments for screen-detected prediabetes … Final
Research Plan
Menopausal Hormone
Therapy to Prevent
Chronic Conditions
Oral Health in Youth … Deficiency
Draft
Research Plan
Folic Acid to Prevent
Neural Tube Defects
Menopausal Hormone
Therapy
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
May 14, 2020 - effect vary between a priori subgroups defined by age, sex, 10-year cardiovascular risk, diagnosis of diabetes … effect vary between a priori subgroups defined by age, sex, 10-year cardiovascular risk, diagnosis of diabetes … with other nonaspirin antithrombotic medications (e.g., warfarin)
Comparisons
Placebo or no treatment
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/tDXRYadTAu6MrMmxU6kqK7
December 01, 2007 - Benefits of Detection and Early Treatment
The USPSTF found good evidence that treatment of
high blood … Clinicians should consider the patient’s overall
cardiovascular risk profile, including smoking, diabetes … Nonpharmacologic Treatment
Nonpharmacologic therapies, such as reduction of di-
etary sodium intake, … The follow
ing nonpharm
acologic therapies are associated w
ith reductions in blood pressure:
• R … anagem
ent
• R
eduction of alcohol intake
A
dults w
ith hypertension should be screened for diabetes